Are connexins, pannexins and their (hemi)channels novel biomarkers and pharmacological targets in the prognosis and therapy of liver cancer? (Toekenning in het kader van bilaterale onderzoekssamenwerking met Brazilië)

Medicine & Life Sciences

1. Pharmacological Biomarkers 100%
2. Liver Neoplasms 98%
3. Connexins 92%
4. Connexin 43 30%
5. Cell Culture Techniques 12%
6. Chronic Disease 12%
7. Therapeutics 12%
8. Animal Models 11%
9. Paracrine Communication 11%
10. End Stage Liver Disease 9%
11. Translational Medical Research 9%
12. Gastroenterology 9%
13. Liver Diseases 6%
14. Disease Progression 6%
15. Pharmacology 5%
16. Biomarkers 5%
17. Pathology 5%